The goal of the Immunohistochemistry and Molecular Pathology Core is to facilitate development andapplication of immunohistochemical and molecular genetic analyses for Cancer Center members.The Core will: ' ' ^1. Develop IHC and in situ hybridization (FISH) based assays for new antibodies and genetic loci incollaboration with CancerCenter Members2. Perform routine immunohistochemical analyses of animal and human tissue sections and cell lines.3. Perform IHC analysis of tissue arrays produced by the Cancer Center Tissue Core.4. Perform FISH analyses for DMA copy number in cell lines, animal models, and human tumors.5. Collaborate with CC Members in microdissection, and extraction of DNA and RNA from tumor sections.6. Perform genomic mapping onto metaphase chromosomes of human and mouse DNA clones7. Perform human and mouse comparative genomic hybridizationThe Core will work closely with other Cores (particularly the Tissue, Genome Analysis, and Array Cores) toallow research protocols to take advantage of the resources and expertise offered within each Core.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA082103-09
Application #
7506539
Study Section
Subcommittee G - Education (NCI)
Project Start
2007-09-25
Project End
2012-05-31
Budget Start
2007-09-25
Budget End
2008-05-31
Support Year
9
Fiscal Year
2007
Total Cost
$117,350
Indirect Cost
Name
University of California San Francisco
Department
Type
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Sannino, Sara; Guerriero, Christopher J; Sabnis, Amit J et al. (2018) Compensatory increases of select proteostasis networks after Hsp70 inhibition in cancer cells. J Cell Sci 131:
Lam, Christine; Ferguson, Ian D; Mariano, Margarette C et al. (2018) Repurposing tofacitinib as an anti-myeloma therapeutic to reverse growth-promoting effects of the bone marrow microenvironment. Haematologica 103:1218-1228
Truillet, Charles; Parker, Matthew F L; Huynh, Loc T et al. (2018) Measuring glucocorticoid receptor expression in vivo with PET. Oncotarget 9:20399-20408
Phillips, Kathryn A; Trosman, Julia R; Deverka, Patricia A et al. (2018) Insurance coverage for genomic tests. Science 360:278-279
Phillips, Kathryn A (2018) Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning? JAMA 319:2379-2380
Puri, Sapna; Roy, Nilotpal; Russ, Holger A et al. (2018) Replication confers ? cell immaturity. Nat Commun 9:485
An, Zhenyi; Aksoy, Ozlem; Zheng, Tina et al. (2018) Epidermal growth factor receptor and EGFRvIII in glioblastoma: signaling pathways and targeted therapies. Oncogene 37:1561-1575
Behr, Spencer C; Villanueva-Meyer, Javier E; Li, Yan et al. (2018) Targeting iron metabolism in high-grade glioma with 68Ga-citrate PET/MR. JCI Insight 3:
Rubenstein, James L; Geng, Huimin; Fraser, Eleanor J et al. (2018) Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma. Blood Adv 2:1595-1607
An, Zhenyi; Knobbe-Thomsen, Christiane B; Wan, Xiaohua et al. (2018) EGFR Cooperates with EGFRvIII to Recruit Macrophages in Glioblastoma. Cancer Res 78:6785-6794

Showing the most recent 10 out of 192 publications